Last update:

Arthritis & Rheumatism news

Arthritis & Rheumatism

Clinical test predicts best rheumatoid arthritis treatment on first try

1 in 100 people in Britain today live with rheumatoid arthritis (RA). Unlike osteoarthritis (OA), RA is caused not by wear and tear but by the body's immune system attacking its own joints. RA can strike quickly at any age—but ...

Arthritis & Rheumatism

Visualizing what happens in inflamed joints of children with arthritis could lead to possible new disease targets

A new study by researchers from the University of Birmingham, UCL, Great Ormond Street Hospital and Birmingham Children's Hospital has revealed important clues into what is driving disease in children with arthritis.

Arthritis & Rheumatism

The many ways that AI enters rheumatology

Artificial intelligence (AI) is entering the mainstream. The term encompasses a wide variety of machines that can learn from data, identify patterns, and make decisions. But how can it be used to support health care? EULAR—The ...

Arthritis & Rheumatism

Osteoarthritis: Too many non-evidence-based therapies?

Osteoarthritis is a leading cause of chronic pain, often affecting physical function, daily activities, and quality of life. EULAR—The European Alliance of Associations for Rheumatology—has developed recommendations and ...

Arthritis & Rheumatism

Exploring patient experiences in juvenile idiopathic arthritis

Adolescents and young adults with chronic diseases need special care—and pediatric rheumatological conditions can persist into adulthood. Two new works presented at the 2025 congress of EULAR—The European Alliance of ...

Arthritis & Rheumatism

Study reveals risk factors for spinal deterioration in r-axSpA

Axial spondyloarthritis (axSpA) is a chronic inflammatory rheumatic musculoskeletal disease that predominantly affects the axial skeleton. axSpA is an umbrella term that comprises the whole spectrum of patients with and without ...

Arthritis & Rheumatism

The value of physical activity for people with RMD

Regular physical activity is increasingly promoted for people with rheumatic and musculoskeletal diseases (RMD) as well as the general population. EULAR—The European Alliance of Associations for Rheumatology—has published ...

Arthritis & Rheumatism

Patient organizations: Supporting RMD patients with education

When receiving a diagnosis of a rheumatic musculoskeletal disease (RMD), people need a lot of information. Some need it all at once, while others may prefer to receive it in smaller portions or like to spread it out. This ...

Arthritis & Rheumatism

First data from the EULAR RheumaFacts project

Rheumatic and musculoskeletal diseases (RMD) are the leading causes of disability worldwide, resulting in significant health care and social support costs. One of the reasons for this increasing burden seems to be the variability ...

Arthritis & Rheumatism

Guidance needed for RMD patients seeking help online

Rheumatic musculoskeletal diseases (RMD) have an important impact on quality of life, and represent an economic burden to society. EULAR—The European Alliance of Associations for Rheumatology—has emphasized the role of ...

Arthritis & Rheumatism

Studies identify predictors and outcomes in systemic sclerosis

The Very Early Diagnosis of Systemic Sclerosis (VEDOSS) criteria identify red flags as puffy fingers, abnormal nailfold capillaroscopy, and specific autoantibodies in patients with Raynaud's phenomenon as a very early disease ...

Medical research

New therapeutic target for osteoarthritis identified

Investigators have discovered that a subset of sensory neurons promote osteoarthritis-related joint pain and inflammation, suggesting a new therapeutic target for pain management, according to findings published in Nature ...

Arthritis & Rheumatism

Understanding opioids in fibromyalgia

Fibromyalgia is common, affecting around 2% of people in the general population. The 2017 EULAR recommendations state that tramadol—a weak opioid—may be considered for pain management in fibromyalgia, but advise against ...

Diseases, Conditions, Syndromes

Liver function tests can ID occult disorders in systemic sclerosis

Liver function test (LFT) screening can identify occult hepatitis, cholestasis, and cholestatic hepatitis in patients with systemic sclerosis (SSc), according to a study published online May 2 in Open Access Rheumatology: ...

Neuroscience

Study investigates how fibromyalgia changes the brain

One of the core symptoms experienced by patients with fibromyalgia is chronic pain. A team from the LWL Clinic for Psychosomatic Medicine and Psychotherapy at Ruhr University Bochum, Germany, has investigated the brain changes ...

Arthritis & Rheumatism

Harmonizing rheumatology training across Europe

Postgraduate rheumatology training programs define the knowledge, skills, and behaviors needed for physicians to become specialists in rheumatology. In some countries there is a standardized approach, but in others the program ...

Arthritis & Rheumatism

TAp63: A new protein drug target for rheumatoid arthritis

Rheumatoid arthritis (RA) is an autoimmune disease characterized by joint deterioration. The clinical outcomes of patients with active RA can be improved using anti-rheumatic medications, such as methotrexate (MTX). Many ...

Medications

Peresolimab found to be efficacious for rheumatoid arthritis

Peresolimab, a humanized immunoglobulin G1 monoclonal antibody designed to stimulate the endogenous programmed cell death protein 1 (PD-1) inhibitory pathway, is efficacious for patients with rheumatoid arthritis, according ...

Arthritis & Rheumatism

New research sheds light on symptoms of understudied spine disease

After hearing firsthand from patients about how the disease impacted their lives, a team of researchers and graduate students at University of Western Ontario were inspired to investigate the symptoms associated with an understudied ...

Arthritis & Rheumatism

Does brepocitinib benefit patients with psoriatic arthritis?

Brepocitinib is an oral drug that inhibits certain enzymes involved in inflammation—called tyrosine kinase 2 and Janus kinase 1—and is being tested for the treatment of several immunological diseases. A phase IIb randomized ...